Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
- PMID: 7726912
- DOI: 10.1038/ng0994-27
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Erratum in
- Nat Genet 1994 Dec;8(4):410
Abstract
The MTS1 gene on chromosome 9p21 encodes the p16 inhibitor of cyclinD/Cdk-4 complexes, and is deleted or mutated in a variety of tumour types. We found allelic deletions of 9p21-p22 in 85% of pancreatic adenocarcinomas. Analysis of MTS1 in pancreatic carcinomas (27 xenografts and 10 cell lines) showed homozygous deletions in 15 (41%) and sequence changes in 14 (38%). These included eight point mutations (four nonsense, two missense and two splice site mutations) and six deletions/insertions, all accompanied by loss of the wild-type allele. Sequencing of MTS1 from primary tumours confirmed the mutations. Coexistent inactivations of both MTS1 and p53 was common and suggests that abnormal regulation of cyclin-dependent kinases may play an important role in the biology of pancreatic carcinoma.
Similar articles
-
Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.Cancer Res. 1996 Mar 1;56(5):1137-41. Cancer Res. 1996. PMID: 8640773
-
MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.Oncogene. 1995 Feb 2;10(3):619-22. Oncogene. 1995. PMID: 7845688
-
The MTS1 gene is frequently mutated in primary human esophageal tumors.Oncogene. 1994 Dec;9(12):3737-41. Oncogene. 1994. PMID: 7970734
-
Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.
-
Molecular genetics of exocrine pancreatic neoplasms.Surg Clin North Am. 1995 Oct;75(5):857-69. doi: 10.1016/s0039-6109(16)46732-0. Surg Clin North Am. 1995. PMID: 7660250 Review.
Cited by
-
Bayesian Hidden Markov Modeling of Array CGH Data.J Am Stat Assoc. 2008 Jun 1;103(482):485-497. doi: 10.1198/016214507000000923. J Am Stat Assoc. 2008. PMID: 22375091 Free PMC article.
-
Tumor suppressor p16(INK4a) inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction.J Cell Sci. 2013 Apr 15;126(Pt 8):1744-52. doi: 10.1242/jcs.113613. Epub 2013 Feb 26. J Cell Sci. 2013. PMID: 23444377 Free PMC article.
-
The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma.Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):77-87. doi: 10.1038/nrgastro.2011.215. Nat Rev Gastroenterol Hepatol. 2011. PMID: 22183185 Review.
-
Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer.FEBS Lett. 2012 Jul 4;586(14):1984-92. doi: 10.1016/j.febslet.2012.01.054. Epub 2012 Feb 3. FEBS Lett. 2012. PMID: 22321641 Free PMC article. Review.
-
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.Gastroenterology. 2022 Aug;163(2):386-402.e1. doi: 10.1053/j.gastro.2022.03.056. Epub 2022 Apr 7. Gastroenterology. 2022. PMID: 35398344 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous